Strongbridge Biopharma   Report issue

For profit Phase 1 Phase 3
Founded: Trevose PA United States (1996)
Status: Acquired by Xeris Pharmaceuticals (2021)

Organization Overview

First Clinical Trial
None
First Marketed Drug
1996
diclofenamide
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

STRONGBRIDGE | STRONGBRIDGE DUBLIN LTD | STRONGBRIDGE US

Active Ingredients

Marketed Drugs (2)

diclofenamide (1958)

levoketoconazole (Recorlev) (2021)

Drugs in Phase 3 Trials (1)

Key: Strongbridge Biopharma (0) Acquired (1)

ketoconazole (nizoral) (6 trials)

Drugs in Phase 1 Trials (1)

Key: Strongbridge Biopharma (0) Acquired (1)

metformin (glucophage) (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 6
  • # of Trial APIs: 2